Holen Sie sich die Stockscreener-App
14.10
2.15%
-0.31
Vorhandelsmarkt:
14.13
0.03
+0.21%
Schlusskurs vom Vortag:
$14.41
Offen:
$14.445
24-Stunden-Volumen:
555.22K
Relative Volume:
0.80
Marktkapitalisierung:
$625.32M
Einnahmen:
$200.93M
Nettoeinkommen (Verlust:
$-18.91M
KGV:
-31.91
EPS:
-0.4419
Netto-Cashflow:
$-9.09M
1W Leistung:
-3.95%
1M Leistung:
+18.19%
6M Leistung:
-27.54%
1J Leistung:
-25.71%
1-Tages-Spanne:
$14.07
$14.59
1-Wochen-Bereich:
$13.79
$14.77
52-Wochen-Spanne:
$11.48
$21.89
Si Bone Inc Stock (SIBN) Company Profile
Firmenname
Si Bone Inc
Sektor
Branche
Telefon
(408) 207-0700
Adresse
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
14.10 | 639.07M | 200.93M | -18.91M | -9.09M | -0.4419 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-06-08 | Eingeleitet | Citigroup | Buy |
| 2021-03-09 | Bestätigt | Needham | Buy |
| 2020-12-16 | Bestätigt | Needham | Buy |
| 2020-08-04 | Bestätigt | Needham | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-05 | Bestätigt | Needham | Buy |
| 2020-02-19 | Eingeleitet | Needham | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-11-12 | Eingeleitet | BofA/Merrill | Buy |
| 2018-11-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-11-12 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-11-12 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Si Bone Inc Aktie (SIBN) Neueste Nachrichten
SIBN (NASDAQ: SIBN) files Form 144 for 3,500 restricted shares - Stock Titan
SI-BONE Inc stock (US8255921098): stable trading ahead of Q2 update and focus on spine implant growt - AD HOC NEWS
SI-BONE Inc. (SIBN) Dips 1.7% as Shares Test Key Support Near $13.70Technical Analysis - thelegaladvocate.com
Trading the Move, Not the Narrative: (SIBN) Edition - Stock Traders Daily
SI-BONE Inc. (SIBN) Edges Lower Amid Consolidation Near Key Support LevelsLow Risk Entry Stocks - thelegaladvocate.com
SI-BONE's strong revenue growth hasn't boosted its share price, raising questions about market sentiment or underlying issues. Caution is advised for investors, with analysts taking a neutral to slightly bearish stance until profitability or improvement is shown. - Moomoo
Si-Bone CFO Anshul Maheshwari sells $68,523 in shares - Investing.com India
Si-Bone CFO Anshul Maheshwari sells $68,523 in shares By Investing.com - Investing.com India
Si-Bone CEO Laura Francis sells $220,000 in company stock By Investing.com - Investing.com Australia
Si-Bone CEO Laura Francis sells $220,000 in company stock - Investing.com
SI-BONE (SIBN) CEO Laura Francis sells 14,957 shares to cover RSU tax bill - Stock Titan
SI-BONE (SIBN) legal chief sells 3,726 shares in tax sell-to-cover - Stock Titan
Tax-related SI-BONE (SIBN) CFO sale of 4,666 shares disclosed - Stock Titan
How much upside is left in Si-Bone (SIBN)? Wall Street analysts think 65.27% - MSN
Earnings call transcript: Si-Bone Q1 2026 beats EPS forecast, stock rises - Investing.com Nigeria
(SIBN) Volatility Zones as Tactical Triggers - Stock Traders Daily
How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27% - Yahoo Finance
SI-BONE stock (US8255921098): Q1 beat and raised FY26 guidance drive gains - AD HOC NEWS
Analysts Have Been Trimming Their SI-BONE, Inc. (NASDAQ:SIBN) Price Target After Its Latest Report - simplywall.st
SiBone $SIBN Shares Bought by HighMark Wealth Management LLC - MarketBeat
SiBone Q1 earnings call highlights - MSN
Analysts Are Bullish on These Healthcare Stocks: SI-Bone (SIBN), Perspective Therapeutics (CATX) - The Globe and Mail
Truist cuts SI-BONE stock price target on conservative guidance By Investing.com - Investing.com Australia
SI-BONE (SIBN) Reports Strong Q1 Earnings and Raises Full-Year G - GuruFocus
Why Si-Bone Stock Soared by Almost 20% on Tuesday - The Motley Fool
Why Si-Bone Stock Soared by Almost 20% on Tuesday - The Motley Fool
SI-BONE 1Q Loss/Shr 10c >SIBN - Moomoo
CCORF Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $27 - 富途牛牛
TD Cowen Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $18 - Moomoo
SIBN Maintained by TD Cowen -- Price Target Lowered to $18 - GuruFocus
SIBN Reiterated by Truist Securities -- Price Target Lowered to $18.00 - GuruFocus
Truist cuts SI-BONE stock price target on conservative guidance - Investing.com UK
SI-BONE targets $230M-$233M 2026 revenue while CMS proposes new DRGs that could add up to $50,000 per Granite procedure - MSN
SI-BONE, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:SIBN) 2026-05-12 - Seeking Alpha
SI-BONE, Inc. (NASDAQ:SIBN) Q1 2026 Earnings Call Transcript - Insider Monkey
SI-BONE net loss hits USD 4.3M in Q1 2026 - Medical Buyer
Needham Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $27 - Moomoo
Truist Lowers Price Target on SI-BONE to $18 From $20, Keeps Buy Rating Rating - Moomoo
SI-BONE Inc (SIBN) Q1 2026 Earnings Call Highlights: Strong Reve - GuruFocus
SI-BONE Surges on Strong Q1, Raises Guidance Amid Innovation Push - BriefGlance
SI-BONE Q1 2026 slides: profitability surges, physician base expands By Investing.com - Investing.com Australia
SiBone Q1 Earnings Call Highlights - inkl
Morgan Stanley Initiates Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $18 - Moomoo
SiBone Q1 2026 Earnings Call Transcript - MarketBeat
Finanzdaten der Si Bone Inc-Aktie (SIBN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):